Evidence map›Paper›PMID 42116387›Full record

ReviewMedicine2026

Rectal metastasis from primary small-cell lung cancer: A case report and literature review.

Weiyu Zhai, Shubiao Chen, Zhongchao Wang

Abstract readCase ReportsReview
In one paragraph

Review in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Weiyu ZhaiDepartment of Oncology, Xinyi People's Hospital, Xuzhou, Jiangsu Province, China.ORCID 0009-0000-4454-4083
Shubiao Chen
Zhongchao Wang

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleSmall-cell lung cancer (SCLC) is a subtype of primary lung cancer that has a very poor overall survival rate because of its propensity for metastasis and incredibly high proliferation rate. For most patients with lung cancer, metastatic disease is discovered at the time of initial diagnosis. About 70% of individuals with SCLC already have metastases in their brain, liver, lymph nodes, and bones at the time of diagnosis. Rectal metastases are uncommon. PATIENT CONCERNS: In this case report, we described a 73-year-old female patient who was diagnosed with neuroendocrine SCLC based on a lung biopsy obtained by needle. The patient had blood in the stool, accompanied by loss of appetite and pain around the umbilicus for 6 months. The symptoms gradually worsened. DIAGNOSES: Rectal pathological results revealed that metastatic poorly differentiated neuroendocrine carcinoma originated from the lung.

interventionsThe patient underwent 4 courses of chemotherapy. OUTCOMES: The hematochezia then subsided, and radiological evaluation of the rectal metastases and primary lung tumors suggested a partial response. LESSONS: When a rectal tumor is identified, it is important to differentiate metastatic diseases and make a definitive diagnosis through detailed immunohistochemical evaluation and systemic imaging surveillance.

Indexed as

Lung NeoplasmsRectal NeoplasmsSmall Cell Lung CarcinomaAgedFemaleHumanscase reportRectal metastasessmall cell lung cancer

Identifiers

PMID42116387
PMCPMC13166636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.